ClinicalTrialsFinder

Hormone Receptor Positive HER-2 Negative Metastatic Breast Cancer Clinical Trials in St Louis, Missouri

1 recruitingSt Louis, Missouri

Showing 1–1 of 1 trials

Recruiting
Phase 1Phase 2

Zunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer With Bone Metastasis

Hormone Receptor Positive HER-2 Negative Metastatic Breast Cancer
Washington University School of Medicine152 enrolled3 locationsNCT06374459